The importance of diversity in clinical trials for Hepatitis C
Aja McCutchen, MD, does a deep dive into why hepatitis C seems to disproportionately affect Black people. She explains the importance of diversity in clinical trials due to genetic, metabolic, social, economic, and cultural factors.
Up Next
Facing stigma as a black hepatitis C patient
Seeking hepatitis C treatment as a young patient of color
Asking questions & accessing resources as a woman of color with hepatitis C
Seeking out a doctor of color as a hepatitis C patient
How blood transfusions for sickle cell may have impacted Hepatitis C rates among black americans
Seeking accessible healthcare for the black community: one woman's journey from homelessness to Hepatitis C survivor
Facing the stigma of a hepatitis C diagnosis
Treatment advancements for Hepatitis C
3 ways to overcome hepatitis C stigma
Taking care of Hepatitis C now and looking toward the future
